OTC/SmallCap IRW

Nel ASA: Signs MoU with Haldor Topsoe for delivery of end-to-end green ammonia and methanol solutions

OSLO, Norway, March 25, 2021 /PRNewswire/ -- Nel ASA (Nel, OSE: NEL) has entered into an MoU with Haldor Topsoe with the intent to offer customers end-to-end green ammonia and methanol solutions, based on globally leading technologies from the two companies. "We are very excited to join forces w...

2021-03-25 16:01 4136

Webcast with Electrolux Chairman and CEO ahead of AGM

STOCKHOLM, March 19, 2021 /PRNewswire/ -- A webcast ahead of the Annual General Meeting with Electrolux Chairman and CEO is now available on www.electroluxgroup.com. As previously communicated, the Annual General Meeting on March 25, 2021 will due to the coronavirus pandemic be held without physi...

2021-03-19 20:37 7541

BioVaxys Enters Agreement With Inotiv To Conduct Preclinical Toxicity Studies For Its Covid-T™ Immunodiagnostic Program

VANCOUVER, BC, March 18, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer applications, announced today that it has entered into an agreement with Bioanalytical Systems, Inc. d...

2021-03-18 20:09 5095

Bambuser Creates New In-Store Solutions Division to Build Digital Opportunities for Physical Retail Environments

STOCKHOLM, March 16, 2021 /PRNewswire/ -- Bambuser today announced the creation of In-store Solutions, a new business unit dedicated to building interactive experiences connecting physical and digital spaces. Serving the evolving needs of businesses such as brick-and-mortar retailers, property ow...

2021-03-16 15:18 3742

BioVaxys Enters Major Bioproduction Agreement With Wuxi Biologics (Hong Kong) Ltd. To Synthesize Proteins For Its SARS-CoV-2 Vaccine And COVID-T™ Immunodiagnostic Programs

VANCOUVER, British Columbia, March 15, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer applications, announced today that it has entered into a major bioproduction agreement w...

2021-03-15 20:00 3600

Sasol issues US dollar senior notes

JOHANNESBURG, March 12, 2021 /PRNewswire/ -- Sasol Limited ("Sasol") herewith announces that its wholly owned subsidiary Sasol FinancingUSA LLC (the "Issuer") has priced an offering of US$-denominated, SEC-registered notes (the "Notes"), including$650 million of senior notes due 2026 (the "2026 N...

2021-03-12 13:29 7106

China grants Lleida.net its fifth patent

MADRID, March 4, 2021 /PRNewswire/ -- The intellectual property authority of the People's Republic of China have granted Lleida.net its fifth patent in that Asian country. The patent, which is valid for a period of 20 years, corresponds to Lleida.net's method for certifying an electronic mail co...

2021-03-04 20:12 3734

Quarterback Services, Archer's local agent in Malaysia, secures 1-year extension of PETRONAS Carigali contract for Well Integrity Services

STOCKHOLM, March 3, 2021 /PRNewswire/ -- Quarterback Services Sdn Bhd, the local agent of Archer Well Company (M) Sdn Bhd (Archer) has secured a one-year extension with PETRONAS Carigali Sdn Bhd (PETRONAS Carigali), a subsidiary of PETRONAS, for the provision of well downhole leak detection servi...

2021-03-03 17:38 1607

Cipla Gulf Expands Partnership with Alvotech for Commercialization of Biosimilars in Australia and New Zealand

MUMBAI, India, March 2, 2021 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced that its subsidiary, Cipla Gulf FZ LCC ("Cipla Gulf') is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines inAustra...

2021-03-02 22:05 6189

Kazia Licenses Cantrixil, a Clinical-stage, First-in-class Ovarian Cancer Drug Candidate, to Oasmia Pharmacetical AB

SYDNEY, March 2, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has entered into an exclusive worldwide license agreement with Oasmia Pharmaceutical AB (STO: OASM), an innovation-focuse...

2021-03-02 07:00 4915

BioVaxys Expanding Technology Platform To Address Emerging SARS-CoV-2 Variants

BVX-0320 and Covid-T to have capability to address UK, Brazilian and South African Virus Variants VANCOUVER, B.C., March 1, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF)("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer app...

2021-03-01 21:00 5973

Announcement of change in the total number of votes in AB SKF

GOTHENBURG, Sweden, Feb. 26, 2021 /PRNewswire/ -- Due to a conversion of shares from Series A to Series B in accordance with AB SKF's Articles of Association, the Company confirms the following. As per 26 February, the Company's share capital amounts to SEK 1,138,377,670 and the total number of ...

2021-02-26 17:27 7195

Electrolux publishes 2020 Annual Report

STOCKHOLM, Feb. 25, 2021 /PRNewswire/ -- Electrolux Annual Report for 2020 has been published on the Group's website as of today. The Annual Report can be downloaded in pdf format here and will be distributed inmid-March 2021 to shareholders who have requested it. "The coronavirus pandemic in 20...

2021-02-25 15:53 5514

Elekta appoints Johan Adebäck as Chief Financial Officer

STOCKHOLM, Feb. 25, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that Johan Adebäck has been appointed as permanent Chief Financial Officer with immediate effect. He has held the position of Acting CFO sinceJune 2, 2020. Prior to the Acting CFO position, Johan Adebäck had been Group Tr...

2021-02-25 14:52 5709

Notice of Ericsson's Annual General Meeting 2021

STOCKHOLM, Feb. 23, 2021 /PRNewswire/ -- The Annual General Meeting of shareholders of Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) will be held on Tuesday, March 30, 2021. Due to the COVID-19 pandemic, the Board of Directors has decided that the Annual General Meeting of shareholders 2021 will...

2021-02-23 16:01 4101

BioVaxys Announces Appointment To Its Scientific Advisory Board

VANCOUVER, B.C., Feb. 22, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), a biotechnology company that is advancing viral and oncology vaccine platforms as well as immuno-diagnostic products, today announced the appointment of Kartik Chandran Ph.D....

2021-02-22 21:00 2737

China Telecom Honored with Three Awards including "Platinum Award", "Best CEO" and "Best Investor Relations Team" by The Asset

HONG KONG, Feb. 22, 2021 /PRNewswire/ -- China Telecom Corporation Limited ("China Telecom" or "the Company"; HKEx: 00728; NYSE: CHA) is pleased to announce that the Company was accredited with "Platinum Award – Excellence in Environmental, Social and Governance" in the poll of "ESG Corporate Awa...

2021-02-22 16:30 6318

Sasol delivered a good set of results for the six months ended 31 December 2020

JOHANNESBURG, Feb. 22, 2021 /PRNewswire/ -- Sasol delivered a good set of results for the six months ended31 December 2020. Our earnings increased by more than 100% to R15,3 billion from R4,5 billion in the prior period. Despite a 23% decrease in the rand/barrel oil price, our adjusted EBITDA de...

2021-02-22 15:21 4505

Elekta establishes office in Egypt to meet growing need for precision radiation medicine

STOCKHOLM, Feb. 22, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it will establish a permanent office inCairo, Egypt, to address the shortage of radiotherapy delivery systems and software solutions that play an integral part in treating cancer and brain disorders. To strengthen i...

2021-02-22 15:03 6921

BioVaxys and BioElpida Sign Term Sheet for Clinical Grade BVX-0918A Bio-production

SIGNIFICANT ADVANCEMENT TOWARDS LAUNCH OF PHASE I OVARIAN CANCER VACCINE TRIAL VANCOUVER, BC, Feb. 18, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys" or "Company") announced today that it has signed a Term Sheet ("Term Sheet") with BioElpida S.A.S. ...

2021-02-18 21:00 5889
1 ... 43444546474849

Week's Top Stories